141 related articles for article (PubMed ID: 35595103)
21. Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells.
Jung-Hynes B; Huang W; Reiter RJ; Ahmad N
J Pineal Res; 2010 Aug; 49(1):60-8. PubMed ID: 20524973
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1.
Ganju A; Chauhan SC; Hafeez BB; Doxtater K; Tripathi MK; Zafar N; Yallapu MM; Kumar R; Jaggi M
Br J Cancer; 2018 Feb; 118(4):587-599. PubMed ID: 29465084
[TBL] [Abstract][Full Text] [Related]
23. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
24. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
Zi X; Grasso AW; Kung HJ; Agarwal R
Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834
[TBL] [Abstract][Full Text] [Related]
25. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM
Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537
[TBL] [Abstract][Full Text] [Related]
26. Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy.
Ruppender N; Larson S; Lakely B; Kollath L; Brown L; Coleman I; Coleman R; Nguyen H; Nelson PS; Corey E; Snyder LA; Vessella RL; Morrissey C; Lam HM
PLoS One; 2015; 10(6):e0130565. PubMed ID: 26090669
[TBL] [Abstract][Full Text] [Related]
27. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines.
Zayzafoon M; Abdulkadir SA; McDonald JM
J Biol Chem; 2004 Jan; 279(5):3662-70. PubMed ID: 14602722
[TBL] [Abstract][Full Text] [Related]
28. Androgen suppresses protein kinase D1 expression through fibroblast growth factor receptor substrate 2 in prostate cancer cells.
Zhang L; Zhao Z; Xu S; Tandon M; LaValle CR; Deng F; Wang QJ
Oncotarget; 2017 Feb; 8(8):12800-12811. PubMed ID: 28077787
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of AGR2 induces cellular senescence in prostate cancer cells.
Hu Z; Gu Y; Han B; Zhang J; Li Z; Tian K; Young CY; Yuan H
Carcinogenesis; 2012 Jun; 33(6):1178-86. PubMed ID: 22467239
[TBL] [Abstract][Full Text] [Related]
30. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
[TBL] [Abstract][Full Text] [Related]
31. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
32. Circadian rhythm in prostate cancer: time to take notice of the clock.
Zhu WZ; He QY; Feng DC; Wei Q; Yang L
Asian J Androl; 2023; 25(2):184-191. PubMed ID: 36073562
[TBL] [Abstract][Full Text] [Related]
33. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cells.
Mak P; Jaggi M; Syed V; Chauhan SC; Hassan S; Biswas H; Balaji KC
Biochem Biophys Res Commun; 2008 Sep; 373(4):618-23. PubMed ID: 18602367
[TBL] [Abstract][Full Text] [Related]
35. Adrenergic Blockade Promotes Maintenance of Dormancy in Prostate Cancer Through Upregulation of GAS6.
Decker AM; Decker JT; Jung Y; Cackowski FC; Daignault-Newton S; Morgan TM; Shea LD; Taichman RS
Transl Oncol; 2020 Jul; 13(7):100781. PubMed ID: 32361123
[TBL] [Abstract][Full Text] [Related]
36. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients.
Karam M; Bièche I; Legay C; Vacher S; Auclair C; Ricort JM
J Cell Mol Med; 2014 Dec; 18(12):2536-52. PubMed ID: 25287328
[TBL] [Abstract][Full Text] [Related]
38. Single-cell sequencing reveals MYC targeting gene MAD2L1 is associated with prostate cancer bone metastasis tumor dormancy.
Wang X; Yu J; Yan J; Peng K; Zhou H
BMC Urol; 2022 Mar; 22(1):37. PubMed ID: 35305591
[TBL] [Abstract][Full Text] [Related]
39. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
Reagan-Shaw S; Ahmad N
FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer cells promote osteoblastic bone metastases through Wnts.
Hall CL; Bafico A; Dai J; Aaronson SA; Keller ET
Cancer Res; 2005 Sep; 65(17):7554-60. PubMed ID: 16140917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
